{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01705",
      "entity_text" : "Syn303",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0037" ],
      "Organ" : [ "uberon:UBERON:0001965" ]
    }
  },
  "verbose_text" : "administration of Syn303 led to an appreciable mAb concentration within the brain that demonstrates effective target engagement (i.e., binding of extracellular pathologic alpha-syn), we measured Syn303 levels in the cerebral spinal fluid (CSF) at 1, 3, and 7 days following a single i.p.",
  "reading_complete" : "2020-08-09T06:22:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T06:20:02Z",
  "trigger" : "levels",
  "evidence" : [ "Syn303 levels" ],
  "pmc_id" : "4410967",
  "score" : 0
}